Related Experiment Videos
Regional fibrinolytic study in coronary artery disease
Insights
Coronary patients exhibit impaired fibrinolysis, a critical blood clotting process. Key protein levels related to clot breakdown were significantly altered, indicating a defective fibrinolytic system in heart disease.
Area of Science:
- Cardiovascular Medicine
- Hematology
- Biochemistry
Background:
- Fibrinolysis, the breakdown of blood clots, is crucial for cardiovascular health.
- Previous research suggests potential alterations in fibrinolytic activity in patients with coronary artery disease.
Purpose of the Study:
- To investigate the status of the fibrinolytic system in patients with coronary artery disease.
- To evaluate specific components of fibrinolysis during cardiac catheterization.
Main Methods:
- Cardiac bilateral catheterization was performed on coronary patients.
- Evaluated tests included Euglobulin lysis time, fibrinogen, plasminogen, antithrombin III (AT III), alpha 1-antitrypsin, and alpha 2-macroglobulin.
- Measurements were taken from various cardiac chambers, as well as arterial and venous systems.
Main Results:
- Fibrinolytic activity was found to be reduced in multiple cardiac chambers.
- Plasminogen levels were elevated, likely due to decreased consumption.
- Levels of alpha 1-antitrypsin and alpha 2-macroglobulin were significantly reduced in both arterial and venous blood.
Conclusions:
- The findings suggest a defective fibrinolytic system in patients with coronary artery disease.
- Altered levels of key fibrinolytic proteins indicate a compromised ability to break down blood clots.
Abstract:
In a group of coronary patients studies of fibrinolysis were carried out during cardiac bilateral catheterization. The following tests were evaluated: Euglobulin lysis time, fibrinogen, plasminogen, AT III, alpha 1-antitrypsin and alpha 2-macroglobulin. Fibrinolytic activity was reduced in various cardiac chambers. Plasminogen levels were elevated probably because of reduced utilization or consumption. Alpha 1-antitrypsin and alpha 2-macroglobulin levels were greatly reduced both in the arterial and in the venous system. From these results the fibrinolytic system may be concluded to be defective in coronary patients.